"Anxiety Relief Without The High? New Studies On CBD, A Cannabis Extract" - Allison Aubrey
As more states legalize marijuana, there's growing interest in a cannabis extract — cannabidiol, also known as CBD. It's marketed as a compound that can help relieve anxiety — and, perhaps, help ease aches and pains, too. Part of the appeal, at least for people who don't want to get high, is that CBD doesn't have the same mind-altering effects as marijuana, since it does not contain THC, the psychoactive component of the plant. A phase 2 clinical trial is exploring whether CBD might help prevent relapse in opioid abusers by reducing craving for the drug. The study’s led by Yasmin Hurd, PhD, professor of psychiatry, neuroscience, pharmacology and systems therapeutics at the Icahn School of Medicine at Mount Sinai and director of the center for addictive disorders at the Mount Sinai Health System. Dr. Hurd has been trying to rally other top scientists to study CBD’s effects and potential benefits in the treatment of substance abuse.
-Yasmin Hurd, PhD, Professor, Psychiatry, Neuroscience, Pharmacology, Systems Therapeutics, Icahn School of Medicine at Mount Sinai, Chair, Ward-Coleman Translational Neuroscience, Director of the Center for Addictive Disorders, Mount Sinai Health System
Additional coverage:
Alabama Public Radio
KPBS
MPR News
Two Leading Mount Sinai Brain Scientists Elected to the National Academy of Sciences
May 05, 2022 View All Press Releases